These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3601797)

  • 1. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas.
    Rutgers DH; Wils IS; Schaap AH; van Lindert AC
    Pathol Res Pract; 1987 Apr; 182(2):207-13. PubMed ID: 3601797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
    Baak JP; Schipper NW; Wisse-Brekelmans EC; Ceelen T; Bosman FT; van Geuns H; Wils J
    Br J Cancer; 1988 May; 57(5):503-8. PubMed ID: 3395555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-flow cytometry of squamous cell carcinomas from the human uterine cervix: the identification of prognostically different subgroups.
    Rutgers DH; van der Linden PM; van Peperzeel HA
    Radiother Oncol; 1986 Nov; 7(3):249-58. PubMed ID: 3809587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
    Volm M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours.
    Trebeck CE; Friedlander ML; Russell P; Baird PJ
    Pathology; 1987 Jul; 19(3):241-6. PubMed ID: 3324024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ploidy as a prognostic factor in ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
    Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in well-differentiated early-stage epithelial ovarian cancer.
    Schueler JA; Cornelisse CJ; Hermans J; Trimbos JB; van der Burg ME; Fleuren GJ
    Cancer; 1993 Feb; 71(3):787-95. PubMed ID: 8431861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
    Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
    Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.
    Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L
    Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic assessment in stage I ovarian cancer using a discriminant analysis with clinicopathological and DNA flow cytometric data.
    Punnonen R; Kallioniemi OP; Mattila J; Koivula T
    Gynecol Obstet Invest; 1989; 27(4):213-6. PubMed ID: 2744626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
    Kaern J; Tropé CG; Kristensen GB; Tveit KM; Pettersen EO
    Am J Obstet Gynecol; 1994 Feb; 170(2):479-87. PubMed ID: 8116701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.
    Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MH
    Pathology; 1984 Jul; 16(3):301-6. PubMed ID: 6514398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
    Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
    Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.